ME03515B - Herstellung von heterodimeren proteinen - Google Patents
Herstellung von heterodimeren proteinenInfo
- Publication number
- ME03515B ME03515B MEP-2019-235A MEP2019235A ME03515B ME 03515 B ME03515 B ME 03515B ME P2019235 A MEP2019235 A ME P2019235A ME 03515 B ME03515 B ME 03515B
- Authority
- ME
- Montenegro
- Prior art keywords
- production
- heterodimeric proteins
- heterodimeric
- proteins
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
- C07K1/113—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure
- C07K1/1133—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure by redox-reactions involving cystein/cystin side chains
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2863—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for growth factors, growth regulators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2887—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against CD20
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/46—Hybrid immunoglobulins
- C07K16/468—Immunoglobulins having two or more different antigen binding sites, e.g. multifunctional antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/31—Immunoglobulins specific features characterized by aspects of specificity or valency multispecific
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/40—Immunoglobulins specific features characterized by post-translational modification
- C07K2317/41—Glycosylation, sialylation, or fucosylation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/52—Constant or Fc region; Isotype
- C07K2317/524—CH2 domain
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/52—Constant or Fc region; Isotype
- C07K2317/526—CH3 domain
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/52—Constant or Fc region; Isotype
- C07K2317/53—Hinge
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/55—Fab or Fab'
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
- C07K2317/732—Antibody-dependent cellular cytotoxicity [ADCC]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
- C07K2317/734—Complement-dependent cytotoxicity [CDC]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Analytical Chemistry (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201161552272P | 2011-10-27 | 2011-10-27 | |
DKPA201100826 | 2011-10-27 | ||
EP12783931.4A EP2771364B1 (de) | 2011-10-27 | 2012-10-26 | Herstellung von heterodimeren proteinen |
PCT/EP2012/071294 WO2013060867A2 (en) | 2011-10-27 | 2012-10-26 | Production of heterodimeric proteins |
Publications (1)
Publication Number | Publication Date |
---|---|
ME03515B true ME03515B (de) | 2020-04-20 |
Family
ID=74672034
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MEP-2019-235A ME03515B (de) | 2011-10-27 | 2012-10-26 | Herstellung von heterodimeren proteinen |
Country Status (1)
Country | Link |
---|---|
ME (1) | ME03515B (de) |
-
2012
- 2012-10-26 ME MEP-2019-235A patent/ME03515B/de unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL282393B (en) | Production of heterodimeric proteins | |
HK1214277A1 (zh) | 生產異源多聚體蛋白質 | |
HK1206639A1 (en) | In vivo production of proteins | |
HUE039003T2 (hu) | Módszer a strukturált fehérjekészítmények elõállítására | |
ZA201208533B (en) | Production of solluble protein solutions from pulses | |
SG11201504694VA (en) | Method for producing a recombinant protein of interest | |
HK1209790A1 (en) | Method of producing recombinant iduronate-2-sulfatase -2- | |
SG10201604562PA (en) | Biotechnological production of 3-hydroxyisobutyric acid | |
GB2494153B (en) | Selection of codecs | |
SG11201403814RA (en) | Production of recombinant proteins with simple glycoforms | |
EP2889368A4 (de) | Proteinproduktionsbeschleuniger | |
SG2014002240A (en) | Production of paraxylene | |
BR112014023176A2 (pt) | Métodos de produção de uma proteína recombinante | |
EP2726652A4 (de) | Verfahren für protein-display | |
HUP1200171A1 (hu) | Módszerek polipeptidek elõállítására | |
EP2737065A4 (de) | Proteinherstellungsverfahren | |
HK1211789A1 (en) | Plants for production of therapeutic proteins | |
EP3560952C0 (de) | Variante des bpifb4-proteins | |
EP2688913A4 (de) | Hochleistungsproduktion rekombinanter proteine | |
EP2855401A4 (de) | Herstellung von bn-verbundstoffen | |
EP2726614A4 (de) | Verbesserung der herstellung von fremdproteinen | |
ME03515B (de) | Herstellung von heterodimeren proteinen | |
GB201101794D0 (en) | Protein production | |
GB201106098D0 (en) | Production of fuels | |
GB201119607D0 (en) | Method of manufacture |